This new publication proposes a review of global pharma trends by 2025 and an analysis of top 20 pharma companies’ performance and strategies
News
With 3 million people affected in France, rare diseases are a major public health issue. 25% of...
This position paper covers the following key issues:
French health authorities intent – cautiously – to facilitate the development of the biosimilars market by: This...